tiprankstipranks
Cocrystal Pharma Inc (DE:8CC1)
BERLIN:8CC1

Cocrystal Pharma (8CC1) Stock News & Sentiment

0 Followers
Cocrystal Pharma selects drug candidate CDI-988 for clinical development
PremiumThe Fly
Cocrystal Pharma selects drug candidate CDI-988 for clinical development
2y ago
Cocrystal Pharma to Present at the Dawson James Securities 2022 Small Cap Growth Conference
PremiumPress Releases
Cocrystal Pharma to Present at the Dawson James Securities 2022 Small Cap Growth Conference
2y ago
Cocrystal Pharma board approves 1-for-12 reverse stock split
PremiumThe Fly
Cocrystal Pharma board approves 1-for-12 reverse stock split
2y ago

News Score - Last 7 Days

Neutral
DE:8CC1
Sector Average
Media Buzz
This Week1 articles
Weekly Average1.5 articles
News Sentiment
This Week50%
Sector Average59%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is DE:8CC1’s Media Buzz Sentiment?
1 articles about DE:8CC1 were published this week. In an average week, 1.5 articles are published.
    What is DE:8CC1’s weekly average amount of articles?
    In an average week, 1.5 articles about DE:8CC1 are published.
      What is DE:8CC1’s News Sentiment?
      50% of articles about DE:8CC1 were positive this week, compared to its sector average of 59%.
        Healthcare Stocks that are Trending in the News
        TALSTalaris Therapeutics
        PCVXVaxcyte
        THCTenet Healthcare
        IXIIXICO plc
        ESTAEstablishment Labs Holdings
        Showing the stocks with the most bullish news sentiment over the past week
        What's Included in PREMIUM?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis